Showing results (81-90 of 218) with videos related to

Sort By:
Pageof 22
Clinical Pharmacology and Therapeutics|April 18, 2019
Integration of Pharmacometrics and Pharmacoeconomics to Quantify the Value of Improved Forgiveness to Nonadherence: A Case Study of Novel Xanthine Oxidase Inhibitors for GoutDaniel Hill-McManus, Scott Marshall, Elena Soto, et al.
British Journal of Clinical Pharmacology|June 5, 2020
Managing access to advanced therapy medicinal products: Challenges for NHS WalesAndrew R Champion, Sian Lewis, Stuart Davies, et al.
British Journal of Clinical Pharmacology|January 22, 2017
Affordable orphan drugs: a role for not-for-profit organizationsElin H Davies, Emma Fulton, Daniel Brook, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|December 16, 2014
Predicting adherence to medications using health psychology theories: a systematic review of 20 years of empirical researchEmily A F Holmes, Dyfrig A Hughes, Valerie L Morrison
The International Journal of Pharmacy Practice|January 29, 2015
Evaluation of a consultant audit and feedback programme to improve the quality of antimicrobial prescribing in acute medical admissionsElaine Roberts, Dalia M Dawoud, Dyfrig A Hughes, et al.
Drug Safety|October 10, 2018
Preventing Future Deaths from Medicines: Responses to Coroners' Concerns in England and WalesRobin E Ferner, Tohfa Ahmad, Zainab Babatunde, et al.
Drug Discovery Today|November 20, 2020
Acceptability of generic versus innovator oral medicines: not only a matter of tasteCatherine Tuleu, Dyfrig A Hughes, David Clapham, et al.
BMJ Case Reports|July 4, 2012
Recurrent Kikuchi-Fujimoto diseaseBrendan Boyd Spooner, Imdadur Rahman, Nigel Langford, et al.
British Journal of Clinical Pharmacology|July 27, 2025
Medication adherence during the run-in phase of clinical trials: A systematic review of methodological and reporting rigourNon Davies, Bernard Vrijens, Daniel F B Wright, et al.
Trials|April 16, 2026
Guideline for the Measurement, Analysis and Reporting of Medication Adherence during the Run-in phase of clinical trials (MARMAR)Non Davies, Bernard Vrijens, Daniel F B Wright, et al.
Pageof 22